Education
About Us
Working with TipRanks
Follow Us
Cyanotech (CYAN)
OTHER OTC:CYAN
CYAN Stock Chart & Stats
$0.35
$0.00(0.00%)
At close: 4:00 PM EST
$0.35
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.21 - $0.57
Previous CloseN/A
VolumeN/A
Average Volume (3M)6.46K
Market Cap
$2.59M
Enterprise Value$13.91M
Total Cash (Recent Filing)$649.00K
Total Debt (Recent Filing)$15.07M
Price to Earnings (P/E)549.9
Beta-0.07
Next Earnings
Jun 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding7,392,243
10 Day Avg. Volume1,585
30 Day Avg. Volume6,463
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.28
Price to Sales (P/S)0.10
P/FCF Ratio-1.72
Enterprise Value/Market Cap5.38
Enterprise Value/Revenue0.55
Enterprise Value/Gross Profit1.72
Enterprise Value/Ebitda15.29
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Revenue StreamsCyanotech sells both finished branded supplements and bulk astaxanthin/spirulina ingredients. This dual model supports revenue resilience across retail/e‑commerce and B2B channels, reducing reliance on a single distribution route and enabling margin mix management over time.
Consistent, If Modest, Revenue GrowthSustained positive top-line growth, even modest, indicates ongoing demand for natural algae-derived ingredients and products. Over 2–6 months this supports operational planning and incremental scale benefits in cultivation and processing, helping stabilize production throughput.
Healthy Gross Margins On ProductA near-30% gross margin shows the core cultivation and processing model can generate product-level profitability. This margin cushion gives management room to invest in yield improvements, marketing, or channel expansion without immediate margin compression at the cost-of-goods level.
Bears Say
Negative Net ProfitabilityDespite product-level margins, the company reports negative net margin, indicating SG&A, interest, or other operating costs outstrip gross profit. Persisting losses erode equity and limit reinvestment capacity, risking long-term competitiveness unless structural cost or revenue improvements occur.
High Financial LeverageMaterial leverage increases financial fixed costs and reduces flexibility to fund operations or capital projects. With elevated debt relative to equity, adverse demand or margin pressure could strain covenant compliance and amplify refinancing risk over the medium term.
Weak Cash GenerationNegative operating cash flow and shrinking free cash flow indicate the business consumes cash to run and grow. This undermines the firm's ability to self-fund capex, pay down debt, or invest in marketing and R&D, increasing reliance on external financing under uncertain conditions.
Cyanotech News
CYAN FAQ
What was Cyanotech’s price range in the past 12 months?
Cyanotech lowest stock price was $0.21 and its highest was $0.57 in the past 12 months.
What is Cyanotech’s market cap?
Cyanotech’s market cap is $2.59M.
When is Cyanotech’s upcoming earnings report date?
Cyanotech’s upcoming earnings report date is Jun 30, 2026 which is in 104 days.
How were Cyanotech’s earnings last quarter?
Currently, no data Available
Is Cyanotech overvalued?
According to Wall Street analysts Cyanotech’s price is currently Overvalued.
Does Cyanotech pay dividends?
Cyanotech does not currently pay dividends.
What is Cyanotech’s EPS estimate?
Cyanotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cyanotech have?
Cyanotech has 7,392,243 shares outstanding.
What happened to Cyanotech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cyanotech?
Currently, no hedge funds are holding shares in CYAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cyanotech
Cyanotech Corporation (CYAN) is a biotechnology company based in Hawaii that specializes in the cultivation and processing of microalgae. Operating primarily in the nutritional supplements and specialty chemical sectors, Cyanotech produces high-quality products such as Astaxanthin, a powerful antioxidant derived from the microalgae Haematococcus pluvialis, and Spirulina, a nutrient-rich blue-green algae. The company's core offerings are focused on health and wellness, catering to consumers seeking natural dietary supplements and functional foods.
Technical Analysis
Nature's Sunshine Products
―
Seneca Foods
―
Hain Celestial
―
USANA Health
―
Laird Superfood
―
Ownership Overview
Options Prices
Currently, No data available
---